The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization

Neumann, Eva; Hennenlotter, Joerg; Todenhoefer, Tilman; Scharpf, Marcus; Neumann, Tim; Schilling, David; Stenzl, Arnulf; Bedke, Jens

dc.contributor.author	Neumann, Eva
dc.contributor.author	Scharpf, Marcus
dc.contributor.author	Neumann, Tim
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Bedke, Jens
dc.contributor.author	Hennenlotter, Jörg
dc.contributor.author	Todenhöfer, Tilman Wolfgang
dc.date.accessioned	2017-12-13T13:05:29Z
dc.date.available	2017-12-13T13:05:29Z
dc.date.issued	2017
dc.identifier.issn	1865-8652
dc.identifier.uri	http://hdl.handle.net/10900/79344
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s12325-017-0510-2	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01254
utue.publikation.seiten	966-974	de_DE
utue.personen.roh	Neumann, Eva
utue.personen.roh	Hennenlotter, Joerg
utue.personen.roh	Todenhoefer, Tilman
utue.personen.roh	Scharpf, Marcus
utue.personen.roh	Neumann, Tim
utue.personen.roh	Schilling, David
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Bedke, Jens
dcterms.isPartOf.ZSTitelID	Advances in Therapy	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	34	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE